Mustang Bio to Participate in Upcoming September 2023 Investor Conferences Sep 7, 2023 08:15AM
Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences Sep 22, 2022 08:30AM
Cantor Fitzgerald Reiterates Overweight Rating on Fortress Biotech (FBIO) on Q1 Report, "Risk-Diversification Remains Attractive " May 13, 2022 06:25AM
Cantor Fitzgerald Reiterates Fortress Biotech (FBIO) at Overweight, $6 PT, "Upward Earnings Estimate Revisions and Multiple Expansion will Drive FBIO's Stock Higher" Apr 6, 2022 06:13AM
Cantor Fitzgerald Reiterates Overweight Rating on Fortress Biotech (FBIO), Sees Upward Earnings Revisions and Multiple Expansion Mar 29, 2022 05:55AM


Mar 10, 2022 08:30AM Mustang Bio to Participate in Three March 2022 Investor Conferences
Mar 10, 2022 08:30AM Mustang Bio to Participate in Three March 2022 Investor Conferences
Mar 9, 2022 09:00AM Fortress Biotech to Participate in Three March 2022 Investor Conferences
Mar 9, 2022 09:00AM Fortress Biotech to Participate in Three March 2022 Investor Conferences
Mar 8, 2022 09:00AM Mustang Bio Completes a $75 Million Debt Financing with Runway Growth Capital
Mar 8, 2022 09:00AM Mustang Bio Completes a $75 Million Debt Financing with Runway Growth Capital
Sep 29, 2021 01:31PM Fortress Biotech (FBIO): 3 Positive Takeaways from AstraZeneca's Deal to Acquire Caelum - Cantor Fitzgerald
May 6, 2021 06:49AM Companies with NDRs 5/06
May 5, 2021 06:40AM Companies with NDRs 5/05
Apr 27, 2021 07:03AM Companies with NDRs 4/27
Apr 26, 2021 06:37AM Companies with NDRs 4/26
Apr 13, 2021 11:06AM Fortress Biotech (FBIO) Reaction 'Overdone' - Cantor Fitzgerald
Dec 10, 2020 07:20AM Companies with NDRs 12/10
Oct 27, 2020 07:08AM Companies with NDRs 10/27
Aug 28, 2020 08:03AM Fortress Biotech (FBIO) Announces $60 Million Loan Agreement with Oaktree Capital Management
Aug 28, 2020 08:00AM Fortress Biotech Announces $60 Million Loan Agreement with Oaktree Capital Management
Aug 28, 2020 08:00AM Fortress Biotech Announces $60 Million Loan Agreement with Oaktree Capital Management
Aug 26, 2020 08:34AM Companies with NDRs 08/26
Aug 25, 2020 07:17AM Companies with NDRs 08/25
Jun 11, 2020 09:02AM Mustang Bio (MBIO) Prices 10.79M Share Common Offering at $3.25/Sh
Jun 11, 2020 09:00AM Mustang Bio Announces Pricing of Public Offering of Common Stock
Jun 11, 2020 09:00AM Mustang Bio Announces Pricing of Public Offering of Common Stock
Jun 10, 2020 04:01PM Mustang Bio (MBIO) to Offer Common Stock
Jun 10, 2020 04:01PM Mustang Bio Announces Proposed Public Offering of Common Stock
Jun 10, 2020 04:01PM Mustang Bio Announces Proposed Public Offering of Common Stock
Feb 13, 2020 09:25AM Pre-Open Stock Movers 02/13: (APT) (RDFN) (FBIO) Higher (XBIT) (AKRX) (NTAP) Lower (more...)
Feb 12, 2020 06:02PM After-Hours Stock Movers 02/12: (RDFN) (FBIO) (AMAT) Higher; (BE) (NTAP) (CSCO) Lower (more...)
Feb 12, 2020 04:14PM UPDATE: Cantor Fitzgerald Starts Fortress Biotech (FBIO) at Overweight
Sep 26, 2019 08:30AM Checkpoint Therapeutics to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
Sep 26, 2019 08:30AM Mustang Bio to Participate in October 2019 Investor Conferences
Sep 26, 2019 08:30AM Fortress Biotech to Present at October 2019 Investor Conferences
Sep 26, 2019 08:30AM Mustang Bio to Participate in October 2019 Investor Conferences
Sep 26, 2019 08:30AM Checkpoint Therapeutics to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
Sep 26, 2019 08:30AM Fortress Biotech to Present at October 2019 Investor Conferences
May 8, 2019 09:25AM Mustang Bio Announces Full Exercise of Option
May 8, 2019 09:25AM Mustang Bio Announces Full Exercise of Option
Apr 30, 2019 10:02AM Mustang Bio (MBIO) Prices 6.875M Shares at $4
Apr 30, 2019 10:01AM Mustang Bio Announces Pricing of Public Offering of Common Stock
Apr 30, 2019 10:01AM Mustang Bio Announces Pricing of Public Offering of Common Stock
Apr 29, 2019 04:02PM Mustang Bio (MBIO) to Offer Common Stock
Apr 29, 2019 04:01PM Mustang Bio Announces Proposed Public Offering of Common Stock
Apr 29, 2019 04:01PM Mustang Bio Announces Proposed Public Offering of Common Stock